Auwaerter on Infectious Diseases

 
 
  • Lyme Testing Gets Fast and Easy   Dr Paul Auwaerter comments on the newly approved, modified two-tier approach for diagnosing Lyme disease.
  • Will This Be the Holy Grail for Sepsis?   An effective intervention for severe sepsis and septic shock can't come soon enough.
  • Severe Malaria: Only One Drug Option Remains   Patient with severe malaria? Call the CDC, rather than the pharmacy, to obtain artesunate.
  • 'Zombie Deer Disease' Spreading; Watch What You Eat   Dr Paul Auwaerter discusses the threat to humans from 'zombie deer disease,' more accurately known as 'chronic wasting disease.'
  • Baloxavir's Place in the Treatment of Flu   We are learning more about baloxavir and how it differs from existing antiviral drugs for treating influenza. Paul Auwaerter describes the drug's potential advantages.
  • Are Showerheads Causing Chronic Lung Infections?   An ecologic study reveals the US hotspots for showerhead biofilms contaminated with mycobacteria and a geographical correlation with nontuberculous mycobacterial lung disease.
  • Oral Antibiotics for Infective Endocarditis: Time to Switch?   The standard of care for endocarditis for many years has been IV antibiotics, even though many patients don't complete the full treatment. Would oral antibiotics work just as well?
  • Fever of Unknown Origin in an Adult-- Periodic Fever Syndromes?   Dr Paul Auwaerter highlights syndromes associated with recurrent fever in adults.
  • A Call for a Lyme Disease Vaccine   With the increase in vector-borne disease, we need more than an ounce of prevention. What we really need is a vaccine for Lyme disease.
  • Consulting an ID Specialist Saves Lives and Money   The value in consulting ID in the management of serious infections is revealed by this recent analysis.
  • Influenza and MRSA Pneumonia   Dr Paul Auwaerter discusses the antimicrobial options for postinfluenza MRSA pneumonia, and makes the case for a universal flu vaccine.
  • A New Way ID Care Is Valued   Dr Paul Auwaerter urges infectious diseases clinicians to review and incorporate into their practice two new CPT codes for prolonged services without direct face-to-face patient contact.
  • California Contagion: How to Control Severe Hepatitis A   Dr Paul Auwaerter discusses California's hepatitis A outbreak and the challenges of testing to avoid false-positives.
  • CMV Disease in the Non-immunosuppressed ICU Patient   Is CMV just a bystander or is it a contributor to critical illness in non-immunosuppressed ICU patients? A new study provides a few answers and raises new questions.
  • Add Legionella to Your Differential Diagnosis for Pneumonia   Don't forget to consider Legionella as a cause of hospital-acquired pneumonia. It's more common and deadlier than some may realize.
  • No New Antibiotics? Go to the Attic, Build Better Mousetraps   Frustrated by the slow development of new antibiotics? Paul Auwaerter, MD, offers a quick review of some of the latest approaches to this problem.
  • Sepsis Guidelines and Antibiotics: Going a Bit Too Far?   Dr Paul Auwaerter points out some of his ID-related concerns with the revised sepsis guidelines.
  • C difficile: Why Good ID Advice Still Matters   Dr Paul Auwaerter addresses some misunderstandings about the management of Clostridium difficile infection that he discovered during his time on a consultation service.
  • Lyme Disease: Treat Mice to Treat Ourselves?   Dr Paul Auwaerter discusses a scientist's proposal to rid areas prone to Lyme disease by making the mice immune to infection with Borrelia burgdorferi, thus breaking the transmission cycle.
  • Candida auris: Time to Prick Up Your Ears?   Candida auris: Have you heard of it yet? Dr Auwaerter discusses this newly identified and potentially drug-resistant isolate and tells clinicians to be on the lookout.